© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0602T involves the measurement of glomerular filtration rate (GFR) through a noninvasive transdermal method. This technique utilizes a specialized sensor device that is applied to the skin to assess kidney function. The primary purpose of GFR measurement is to monitor kidney health, evaluate kidney disease, and prevent misdiagnosis related to the staging of kidney conditions. Unlike traditional methods that require blood samples to estimate GFR, this procedure allows for real-time monitoring of kidney function without the need for invasive blood draws. The estimated GFR is a common clinical practice; however, it relies on serum creatinine levels, which can be influenced by various factors and may not provide timely or accurate reflections of kidney function. The transdermal sensor is designed to measure the actual clearance of a fluorescent pyrazine tracer agent, which is administered as a single intravenous bolus dose. This agent disperses into the extracellular space and is subsequently cleared by the kidneys, allowing for direct measurement of GFR. The sensor's technology includes a fiber optic bundle that captures and processes the emitted fluorescent light from the tracer, converting it into a digital readout for analysis. This innovative approach enhances the accuracy of kidney function assessments and provides valuable insights into renal health.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.